Uric Acid: What High Levels Mean Beyond Gout: Kidneys, Heart and Metabolism

A pocket meter the size of a car key, a drop of blood, and a number that a stranger on your feed insists is ‘the metabolic marker your doctor ignores.’ That is the shape of the uric acid conversation as of mid-2025. Home testing kits, podcast episodes on fructose and a steady drumbeat of posts linking this one lab value to kidney failure, heart attacks and belly fat have pushed a quiet gout chemical into wellness celebrity.

The timing is not random. Over the past few years, a cluster of large randomized trials finally asked the question the posts assume is settled: if we lower uric acid in people who do not have gout, do their kidneys and hearts do better? The answers were sobering, and they are the reason physicians and influencers currently seem to be describing two different molecules.

This piece is about the real one. What the number measures, what it genuinely predicts, where the crystals do damage, and where the evidence simply runs out.

What is uric acid, and where does it actually come from?

Every cell in your body contains DNA and RNA, and both are built partly from purines, nitrogen-containing building blocks that also arrive in food. When old cells are recycled or purine-rich meals are digested, the purines are broken down step by step until an enzyme called xanthine oxidase converts the last intermediates into uric acid. In most mammals the story continues: an enzyme called uricase breaks uric acid down further into a very soluble compound that washes out easily. Humans lost a working uricase gene millions of years ago, which is why our blood carries uric acid levels several times higher than a dog’s or a rat’s.

Roughly two-thirds of the uric acid you produce each day comes from your own cell turnover, not from your plate. The remaining third traces back to diet, particularly organ meats, shellfish, beer and, through a separate chemical route, fructose. About 70 percent of what you make leaves through the kidneys, where it is filtered, mostly reabsorbed, and then partly secreted again. The gut handles the rest.

That reabsorption step matters more than most people realize. The kidney actively pulls uric acid back into the blood through transporter proteins, and genes controlling those transporters explain much of why one person runs a high level on a plain diet while another stays low on beer and steak. Among people with hyperuricemia, the medical term for an elevated blood uric acid level, around 90 percent under-excrete rather than overproduce.

Some researchers have long asked whether this evolutionary quirk had a purpose. Uric acid is a potent antioxidant in the bloodstream, accounting for a large share of plasma antioxidant capacity, and it may have helped early humans retain salt and fat during scarcity. That same salt-and-fat thrift is, in a modern food environment, part of the problem.

What does a uric acid test measure, and what is the uric acid normal range?

A uric acid blood test measures the concentration of uric acid dissolved in your serum, the liquid part of blood. It does not measure crystals, inflammation or kidney damage; it reports a single snapshot of how much is circulating at that moment. Levels drift through the day, rise after a heavy meal or alcohol, climb with dehydration, and fall during an acute gout flare, which is why a normal result taken on a swollen-toe morning does not rule gout out.

Reference ranges vary by laboratory, but most quote roughly 3.5 to 7.2 mg/dL for men and 2.5 to 6.0 mg/dL for women, according to MedlinePlus. Women run lower before menopause because estrogen helps the kidneys excrete uric acid; after menopause the sex gap narrows. Many laboratories now report the result in micromoles per liter instead, where 6.0 mg/dL equals about 357 µmol/L.

The number that matters physically is not the lab’s upper limit but the solubility threshold. At body temperature and normal blood pH, uric acid stays dissolved up to about 6.8 mg/dL. Above that line it can begin to precipitate as monosodium urate crystals, especially in cooler, acidic or previously injured tissues. This is why gout guidelines steer treatment toward a long-term level below 6.0 mg/dL rather than simply ‘inside the normal range.’ A result of 7.0 might sit within a laboratory’s reference interval and still be above the point where crystals form.

A separate 24-hour urine uric acid test measures how much the kidneys excrete in a day. Clinicians order it to work out whether a person’s problem is overproduction or under-excretion, and to assess risk in people who form uric acid kidney stones. It is not a screening test for the general public.

What changed recently

The current wave of attention sits on top of a decade of trials that reshaped what doctors can honestly claim about uric acid.

In March 2018 the CARES trial, published in the New England Journal of Medicine, compared two urate-lowering medicines, febuxostat and allopurinol, in people with gout and established cardiovascular disease. Overall cardiovascular events were similar, but deaths from cardiovascular causes were higher with febuxostat, which led to a boxed warning in the United States. The FAST trial, published in The Lancet in November 2020 and run across the UK and Denmark, then found no excess cardiovascular risk with febuxostat compared with allopurinol, leaving the question contested.

June 2020 brought two randomized trials that tested the kidney hypothesis directly. CKD-FIX, in people with moderate-to-advanced chronic kidney disease, and PERL, in people with type 1 diabetes and early kidney changes, both gave allopurinol or placebo for two to three years. Neither showed a slower decline in kidney function despite substantial falls in uric acid.

Then in October 2022 the ALL-HEART trial, published in The Lancet, randomized nearly 5,700 older adults with ischemic heart disease but no gout to allopurinol or usual care and followed them for almost five years. There was no reduction in heart attack, stroke or cardiovascular death.

On the clinical side, the American College of Rheumatology’s 2020 gout guideline reaffirmed allopurinol as the preferred first-line urate-lowering medicine and advised against urate-lowering treatment for people with asymptomatic hyperuricemia. The viral framing of uric acid as a number everyone should aggressively push down arrived, in other words, just after the evidence stopped supporting it.

What does high uric acid do to your body?

Think of uric acid as a solute with a temper. Dissolved, it is largely inert and even useful as an antioxidant. Precipitated into needle-shaped monosodium urate crystals, it is one of the most reliable triggers of acute inflammation in the body.

The crystal effects are the ones we understand best, because you can see them under a microscope:

• In joints and the tissues around them, crystals provoke gout: sudden, severe inflammatory arthritis, and over years, firm lumps called tophi that can erode bone.
• In the urinary tract, uric acid itself (not the sodium salt) can crystallize in acidic urine and form kidney stones, which account for roughly 5 to 10 percent of stones overall.
• In rare settings such as tumor lysis, when large numbers of cancer cells die at once, a flood of uric acid can clog the kidney’s filtering tubules and cause acute kidney injury.

The second category is murkier. Soluble uric acid, at levels well below the crystal threshold, tracks closely with a long list of conditions: high blood pressure, chronic kidney disease, type 2 diabetes, fatty liver, atrial fibrillation and cardiovascular death. In laboratory studies, uric acid can stiffen blood vessel linings, activate the renin-angiotensin system that raises blood pressure, and drive inflammation in fat and liver cells.

What those studies cannot settle is direction. People with insulin resistance retain more uric acid in the kidney; people with failing kidneys clear less; people who drink heavily or eat large amounts of fructose raise both their uric acid and their cardiometabolic risk through parallel routes. A high reading is therefore an honest warning light, but it is often reporting on the engine rather than being the fault itself.

What is gout, and why does it so often start in the big toe?

Gout is an inflammatory arthritis caused by monosodium urate crystals depositing in and around a joint. It is the most common inflammatory arthritis in men and affects an estimated 4 percent of adults in the United States, according to data cited by the National Institutes of Health. Prevalence rises with age, kidney disease, diuretic use and body weight, and it has climbed steadily over the past three decades.

A classic first attack arrives at night. One joint, most often at the base of the big toe, becomes hot, swollen, shiny and so tender that the weight of a bedsheet is intolerable. Peak pain comes within 12 to 24 hours and, left alone, the episode settles over one to two weeks. The big toe’s starring role is physics rather than mystery: it is the coolest, most distant joint, it bears mechanical stress all day, and crystal solubility falls as temperature drops. Ankles, knees, fingers and elbows follow in frequency.

Between attacks the joint can feel entirely normal, which is the trap. Crystals keep accumulating silently if the uric acid level stays above the solubility threshold. Flares then become more frequent, last longer and involve more joints, and after years tophi can appear on fingers, elbows, ears and feet.

Diagnosis is clinical in many cases, but the gold standard is drawing fluid from the joint and finding the crystals under polarized light. That step also excludes septic arthritis, an infected joint that can look identical and is a medical emergency. Ultrasound and a specialized CT scan can now show urate deposits without a needle.

Importantly, only about one in five people with hyperuricemia ever develops gout. High uric acid is necessary for the disease but far from sufficient.

Uric acid and kidney disease: stones, crystals and a chicken-and-egg problem

The kidney is where uric acid is most intimately involved, and also where the evidence is most tangled.

Start with what is undisputed. Uric acid kidney stones form when urine is persistently acidic, concentrated and rich in uric acid. Unlike calcium stones they are usually invisible on plain X-ray and, uniquely among stone types, can sometimes be dissolved by making the urine less acidic under medical supervision. People with gout, metabolic syndrome, type 2 diabetes and chronic diarrhea are at higher risk. Chronic kidney disease, usually shortened to CKD, is a gradual loss of kidney filtering function measured by the estimated glomerular filtration rate, or eGFR. As eGFR falls, uric acid clearance falls with it, so almost everyone with advanced CKD has elevated uric acid. That alone guarantees a strong statistical association.

The scientific question for two decades has been whether the association runs the other way too. Animal studies suggested that soluble uric acid narrows the tiny arteries feeding the kidney’s filters and promotes scarring. Observational cohorts found that higher baseline uric acid predicted later CKD even after adjusting for blood pressure and diabetes. Small early trials hinted that allopurinol slowed decline.

CKD-FIX and PERL, the two larger placebo-controlled trials published in 2020, were designed to settle it. Participants’ uric acid fell by roughly a third. Kidney function declined at the same rate in both arms. A reasonable reading is that by the time kidney disease is established, lowering uric acid does not change its course, though the trials cannot exclude a benefit from treating much earlier or in different populations.

For patients the practical takeaway is narrower than the headlines: in CKD, a high uric acid level is a reason to review medicines, fluids and gout risk with a nephrologist, not a target to chase on its own.

Does uric acid cause heart disease, or just travel with it?

Cardiologists have been arguing about this since the 1950s, and the honest answer is still ‘mostly travels with it.’

The correlations are real and consistent. Across large cohorts such as the Framingham study and later meta-analyses, people in the top range of uric acid have a higher incidence of hypertension, coronary disease, heart failure, atrial fibrillation and cardiovascular death than those in the bottom range. Uric acid rises before blood pressure in adolescents, and in people with gout the risk of heart attack is roughly 1.5 times that of people without gout.

Mechanistic studies supply a plausible story. Xanthine oxidase, the enzyme that makes uric acid, also generates reactive oxygen species that damage the vessel lining. Soluble uric acid can reduce nitric oxide, the molecule that relaxes arteries, and stimulate the smooth muscle cells in vessel walls. Allopurinol, which blocks xanthine oxidase, improves blood vessel function in small physiological studies.

Randomized outcome trials have been less kind to the hypothesis. ALL-HEART gave allopurinol for a median of nearly five years to older adults with known ischemic heart disease and found no difference in heart attacks, strokes or cardiovascular deaths. The CARES and FAST trials compared two uric-acid-lowering medicines against each other rather than against placebo, so they cannot show whether lowering uric acid itself helps; they mainly examined the safety of one medicine relative to the other.

Genetic studies, which use inherited variants in uric acid transporter genes to mimic a lifelong randomized experiment, mostly point the same way: variants that raise uric acid raise gout risk sharply but have little or no effect on coronary disease. Uric acid, in the cardiologist’s phrase, looks like a marker rather than a maker. A high level should prompt attention to blood pressure, lipids, glucose and weight, which are the targets with proven payoff.

Uric acid, insulin resistance and fatty liver: the metabolism connection

If there is one setting where uric acid may be more than a bystander, it is the chemistry of fructose.

Fructose is the sugar that makes up half of table sugar and most high-fructose corn syrup. Unlike glucose, the liver metabolizes it without any brake, and the first step consumes cellular energy currency so fast that purine breakdown products spike and uric acid rises within minutes of a sugary drink. Sweetened beverages are among the strongest dietary predictors of gout in cohort studies, stronger than red meat in several analyses.

Insulin resistance, the state in which muscle and liver cells respond sluggishly to insulin, is the hub of metabolic syndrome, the cluster of abdominal obesity, raised blood pressure, high triglycerides, low HDL cholesterol and elevated fasting glucose. High insulin levels signal the kidney to hold on to sodium and uric acid, so uric acid climbs as insulin resistance deepens. This single mechanism explains a large part of why uric acid correlates with waist size, blood pressure and diabetes risk at the same time.

Fatty liver, now formally called metabolic dysfunction-associated steatotic liver disease, shows the same pattern. Observational studies find that higher uric acid predicts later fatty liver, and experimental work suggests uric acid can push liver cells to store fat and release inflammatory signals.

Here the randomized evidence is thin rather than negative. A handful of small trials of urate-lowering medicines in people with metabolic syndrome or fatty liver have reported modest changes in blood pressure or liver enzymes, but none were large enough or long enough to measure outcomes that matter to patients. The evidence that does hold up is lifestyle evidence: weight loss, cutting sugary drinks and treating sleep apnea all lower uric acid and improve the metabolic picture together, because they act upstream of both.

What the evidence actually says, graded

Not every claim about uric acid stands on the same footing. A useful habit is to ask what kind of study sits beneath each statement.

Strong evidence (randomized trials plus mechanism): lowering uric acid below the crystal threshold in people with gout reduces flares over time and shrinks tophi. Allopurinol as first-line therapy, started at a low dose and adjusted to target, is supported by multiple trials and every major guideline. Treating acute flares early with anti-inflammatory medicines shortens them.

Moderate evidence (consistent observational data, some trials): high uric acid predicts future gout, uric acid kidney stones, hypertension and chronic kidney disease. Sugary drinks and alcohol, particularly beer, raise uric acid and gout risk. Weight loss lowers uric acid. Some blood pressure medicines raise it (thiazide diuretics) and one lowers it (losartan), which clinicians can factor into prescribing.

Weak or negative evidence (randomized trials failed to confirm the hypothesis): lowering uric acid in people with established chronic kidney disease to slow its progression (CKD-FIX, PERL). Lowering uric acid in people with ischemic heart disease to prevent cardiovascular events (ALL-HEART). Treating asymptomatic hyperuricemia with medicines to prevent anything other than gout.

Expert opinion and laboratory hypothesis only: uric acid as a direct cause of insulin resistance, fatty liver or dementia in humans; home uric acid tracking as a tool for the general population; specific ‘uric acid diets’ beyond the standard advice above.

Where the evidence is negative rather than absent, honesty requires saying so. The CKD and heart trials were large, well run and published in leading journals; they did not simply fail to find an effect because they were small.

Uric acid and your organs at a glance

The table below condenses the previous sections into a single view. ‘Observational’ means studies that follow groups of people and look for patterns; ‘randomized trial’ means people were assigned by chance to a treatment or a comparison, the design that can prove cause and effect.

Outcome	Observational link with high uric acid	What randomized trials of lowering uric acid show	Overall strength
Gout flares and tophi	Very strong; risk rises steeply above 7 mg/dL	Fewer flares and smaller tophi once levels are kept below target	Strong
Uric acid kidney stones	Strong, especially with acidic urine	Alkalinizing urine and lowering urate reduce recurrence in stone formers	Moderate to strong
Chronic kidney disease progression	Moderate; partly explained by reverse causation	No slowing of decline in CKD-FIX or PERL	Negative for treatment
Heart attack, stroke, cardiovascular death	Moderate; weakens after adjusting for other risk factors	No benefit in ALL-HEART; febuxostat safety debated (CARES vs FAST)	Negative for treatment
High blood pressure	Moderate; uric acid precedes hypertension in young people	Small, short trials show modest reductions; no outcome data	Weak
Insulin resistance and fatty liver	Moderate; shared fructose and insulin pathways	Few small trials, no patient-relevant outcomes	Weak

Two patterns stand out. Wherever crystals are the mechanism, treatment works. Wherever soluble uric acid is proposed as the culprit, treatment has either not been tested properly or has been tested and found wanting. That split is the most useful thing a reader can carry away from the whole debate.

How to lower uric acid without medication: what actually moves the number

Lifestyle changes lower uric acid modestly, typically by around 1 mg/dL, which is often enough to matter for someone hovering near the crystal threshold and rarely enough on its own for someone with established gout. Knowing what moves the number most helps you spend effort wisely.

Weight loss is the heavyweight. In people with obesity, losing weight reduces both uric acid production and insulin-driven retention, and bariatric surgery studies show large sustained falls. Crash dieting and fasting, by contrast, can spike uric acid temporarily and trigger a flare, because rapid tissue breakdown releases purines and ketones compete with uric acid for excretion.

Drinks matter more than most foods. Beer carries both alcohol and purines; spirits raise levels through alcohol alone; wine in moderation has the weakest association. Sugar-sweetened sodas and fruit juices raise uric acid through fructose, while whole fruit, with its fiber and lower fructose load, does not appear to raise gout risk. Coffee is consistently associated with lower uric acid and lower gout incidence in cohort studies, likely because its compounds mildly inhibit xanthine oxidase.

On the plate, the classic advice holds: limit organ meats, anchovies, sardines and other very purine-dense foods, moderate red meat and shellfish, and do not fear purine-rich vegetables such as spinach, mushrooms and lentils, which do not raise gout risk in studies. Low-fat dairy is associated with lower levels. A Mediterranean or DASH pattern, both built around vegetables, whole grains, legumes and limited sugar, lowered uric acid in trials originally designed for blood pressure.

Hydration keeps urine dilute, which is particularly relevant for stone formers. Vitamin C supplements showed a small uric-acid-lowering effect in some trials and none in a trial of people with gout, so the evidence is mixed. Anything beyond these basics belongs in a conversation with a clinician, not a supplement cart.

What medication is commonly used to treat gout?

Gout treatment works on two timelines, and confusing them is a common reason people feel let down by their medicines.

The first timeline is the flare. Anti-inflammatory medicines calm an acute attack and work best when started within hours of the first twinge. The main options are non-steroidal anti-inflammatory drugs such as naproxen or ibuprofen, colchicine, and corticosteroids such as prednisone, given by mouth or injected into the joint. Which one a clinician chooses depends on kidney function, stomach history, heart disease and other medicines, which is why self-selecting from a cabinet is a poor idea.

The second timeline is prevention, called urate-lowering therapy. Allopurinol, which blocks xanthine oxidase, is the first-line choice in the American College of Rheumatology, NHS and most international guidelines, and it has been in use for more than fifty years. Febuxostat works the same way and is used when allopurinol is not tolerated or not suitable, with the cardiovascular safety discussion from CARES and FAST factored in. Probenecid increases uric acid excretion by the kidney and suits selected patients with normal kidney function. Pegloticase, an infused enzyme that breaks uric acid down, is reserved for severe tophaceous gout that has not responded to other treatment.

Two features of urate-lowering therapy surprise people. First, it is adjusted gradually to a target level, usually below 6.0 mg/dL and lower when tophi are present, with blood tests guiding each step. Second, flares often increase in the first months because dissolving crystals shed fragments, so clinicians typically prescribe a low-dose anti-inflammatory alongside for a period. Stopping the medicine when the first flare of therapy arrives is the most common way treatment fails.

Allopurinol can rarely cause a serious skin and organ hypersensitivity reaction, more common in people carrying a specific gene variant found at higher rates in some Asian and African ancestry groups; many clinicians test for it before prescribing. All of these decisions, including whether to start at all, sit with the prescribing clinician.

Common myths about uric acid, corrected

The viral version of this topic contains a handful of claims that deserve a direct response.

‘Everyone should know their uric acid and keep it as low as possible.’ No major guideline recommends routine screening in people without symptoms, and the trials that tried lowering uric acid in people without gout to protect kidneys or hearts did not show benefit. Very low levels, moreover, have been associated in observational studies with neurological disease, which is unexplained but argues against treating lower as automatically better.

‘Gout is a disease of rich men who eat too much.’ Genetics explain more of the variation in uric acid than diet does; the kidney’s reabsorption genes, not the dinner table, do most of the work. Women after menopause, people with kidney disease and people taking diuretics make up a large share of patients.

‘A normal uric acid result rules out gout.’ Levels frequently drop during a flare. Clinicians interpret the number alongside the story and, when needed, joint fluid.

‘Cherry juice or apple cider vinegar can replace medicine.’ Cherry intake is associated with fewer flares in one observational study; that is interesting, not proof, and no food has been shown to shrink tophi. Vinegar has no supporting evidence.

‘Fruit is dangerous because of fructose.’ Whole fruit does not raise gout risk in large cohorts; sweetened drinks and juices do.

‘Home meters give you the same information as a lab.’ Fingerstick meters are less accurate and more variable than laboratory serum tests, and a trend in isolation, without a clinician interpreting it against kidney function and medicines, can generate anxiety faster than insight.

‘Lowering uric acid will lower my blood pressure and protect my heart.’ Small short trials hint at blood pressure effects; the only large outcome trial in heart disease found none.

High uric acid symptoms: what to watch for, and what 'silent' really means

Here is the uncomfortable fact behind the trend: high uric acid usually has no symptoms at all. Most people who carry a level above the laboratory range will never know unless a blood panel happens to include it. Hyperuricemia is a measurement, not a feeling.

When symptoms do appear, they come from crystals, and they are hard to miss. The hallmark is a sudden, intensely painful, swollen and red joint, classically the big toe, ankle or knee, often starting overnight and peaking within a day. A low-grade fever can accompany a large-joint flare. Over years, firm chalky lumps under the skin of the fingers, elbows, ears or feet signal tophi.

Kidney involvement announces itself differently: a sharp, cramping pain that starts in the flank and may travel toward the groin, blood visible in the urine, or an urge to pass urine with little result. These point to a stone on the move. Changes in urine volume, swelling of the ankles or unexplained fatigue can accompany reduced kidney function from any cause and are not specific to uric acid.

Many people searching for ‘high uric acid symptoms’ are actually trying to attach a cause to tiredness, joint aches or weight gain after seeing a borderline number. A uric acid level in the sevens does not cause fatigue, generalized aching or brain fog on its own; if those symptoms are present, the number is far more likely to be a passenger alongside sleep apnea, insulin resistance or thyroid changes than the driver.

The practical stance is calm but attentive. A moderately raised level without symptoms is a prompt to look at blood pressure, waist, glucose, alcohol and sugary drinks, and to repeat the test after a few weeks of ordinary eating, rather than a verdict.

When to see a doctor

Some situations connected with uric acid need prompt medical attention; others need a scheduled conversation. Both deserve a professional rather than a search bar.

Seek urgent care the same day if you have:

• A hot, swollen, intensely painful joint together with fever, chills or feeling generally unwell. An infected joint can mimic gout exactly and can destroy cartilage within days.
• Severe flank or abdominal pain with vomiting, fever, or inability to pass urine, which can indicate a stone blocking the kidney.
• Visible blood in the urine, especially with pain.
• A widespread rash, mouth sores, fever or jaundice within the first weeks or months of starting allopurinol or any new urate-lowering medicine, which can signal a rare but serious hypersensitivity reaction.

Book a routine appointment if a blood test shows raised uric acid, even without symptoms. Your clinician can repeat the test, review medicines that raise levels such as diuretics and low-dose aspirin, check kidney function and screen for the metabolic conditions that commonly travel with it. Make the same appointment if you have had two or more joint flares in a year, if flares are involving more than one joint, if you notice lumps under the skin, if you have a history of kidney stones, or if you have gout and chronic kidney disease, heart disease or are planning a pregnancy.

If you already take a gout medicine, do not stop or change it because of a flare, a home meter reading or something you read online. Early flares after starting treatment are expected, not a sign of failure. Any adjustment, including whether a urate-lowering medicine is right for you at all, belongs with the prescribing clinician, who can weigh your level against your kidneys, your heart and the rest of your medicines.

Frequently asked questions

What does high uric acid do to your body?

Above about 6.8 mg/dL uric acid can form crystals that cause gout in joints and uric acid stones in the kidneys; those effects are proven. At lower, soluble levels it is statistically linked with high blood pressure, kidney disease, diabetes and heart disease, but trials of lowering it have not shown protection, so in those settings it behaves mainly as a warning marker.

What does a uric acid test measure?

A serum uric acid test measures how much uric acid is dissolved in the liquid part of your blood at that moment. It does not detect crystals or inflammation. A separate 24-hour urine test measures how much the kidneys excrete daily and helps distinguish overproduction from under-excretion, mainly in people with gout or kidney stones.

What is the uric acid normal range?

Most laboratories quote roughly 3.5 to 7.2 mg/dL for men and 2.5 to 6.0 mg/dL for women, though ranges vary and some report micromoles per liter. The physical threshold for crystal formation is around 6.8 mg/dL, so a result can sit inside a reference range and still be high enough to seed gout over time.

What is gout?

Gout is an inflammatory arthritis caused by monosodium urate crystals depositing in and around a joint, most often the base of the big toe. Flares are sudden, severe and typically settle within one to two weeks, but crystals keep accumulating between attacks if uric acid stays high. Diagnosis is confirmed by finding crystals in joint fluid.

What medication is commonly used to treat gout?

Acute flares are usually treated with non-steroidal anti-inflammatory drugs, colchicine or corticosteroids. Long-term prevention relies on urate-lowering medicines, with allopurinol as the first-line choice in major guidelines and febuxostat, probenecid or pegloticase used in specific situations. Which medicine suits you depends on kidney function and other conditions, and the choice belongs with your prescribing clinician.

Is uric acid and kidney disease a two-way relationship?

Partly. Failing kidneys clear less uric acid, so levels rise as kidney function falls, and uric acid stones and crystal-related injury can directly harm kidneys. Whether soluble uric acid drives chronic kidney disease is unproven: the CKD-FIX and PERL trials lowered uric acid for years without slowing kidney decline.

How to lower uric acid naturally?

Weight loss, cutting sugar-sweetened drinks, limiting beer and spirits, moderating red meat and organ meats, choosing low-fat dairy and staying hydrated each lower uric acid modestly, typically by around 1 mg/dL combined. Coffee and a Mediterranean or DASH eating pattern are associated with lower levels. These changes rarely replace medicine in established gout.

Can high uric acid cause high blood pressure or heart attacks?

Higher uric acid predicts hypertension and cardiovascular events in observational studies, and laboratory work offers plausible mechanisms. The decisive test, the ALL-HEART trial, gave allopurinol to adults with heart disease for nearly five years and found no reduction in heart attacks, strokes or cardiovascular deaths, so current evidence treats uric acid as a marker rather than a cause.

Should I treat high uric acid if I have no symptoms?

Current guidelines advise against urate-lowering medicines for asymptomatic hyperuricemia because trials have not shown benefit for kidneys or heart, while medicines carry their own risks. A raised level is still worth a clinician’s review of blood pressure, glucose, kidney function and medicines such as diuretics, plus lifestyle changes.

Are home uric acid meters accurate?

Fingerstick meters are less accurate and more variable than laboratory serum tests, and readings swing with meals, alcohol, hydration and flares. They are not recommended for screening the general population. If you have gout and your clinician is adjusting treatment to a target, laboratory testing remains the standard for those decisions.

References

• Uric Acid Test, MedlinePlus
• Gout, NHS
• Hyperuricemia (High Uric Acid Level), Cleveland Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.